Repligen (RGEN) Q3 2026 Earnings Call Transcript
BioLife acquisition bolsters cell therapy as chromatography and proteins surge.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
Anglo American’s (AAL LN) Sanches Says Brazil Needs to ‘Negotiate With Everyone’
Anglo American Plc’s top executive in Brazil says the nation should avoid picking sides in the global race for critical minerals and seek to supply nations across geopolitical blocs.
Pork Slump Worsens as High Gas Prices Curb Road Trip Pit Stops
The US pork industry, already struggling with weak demand, is facing another blow: high gasoline prices.
Micron Technology Stock: Is Now the Time for Investors to Take Profits or Buy More?
Key PointsMicron Technology has generated massive growth in the past year due to a shortage of memory products.
PayPal (PYPL) Q3 2026 Earnings Call Transcript
Lores discusses cost savings, Venmo growth, and AI integration driving margin expansion.
Airbnb vs. GameStop: Will Consumers Going Out or Staying In Benefit One of These Stocks More in 2026?
Key PointsAirbnb maintains high net margins and double-digit revenue growth through its global host network.
Bluebulb Takes the Future of Enterprise Treasury to Moonshot 2026
Africa is building ambitious businesses. But ambition alone cannot move money, manage liquidity or power international growth. That requires financial infrastructure built for scale.